MSB 1.82% 94.3¢ mesoblast limited

Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-109

  1. 15,618 Posts.
    lightbulb Created with Sketch. 5701
    My track record ... that's hilarious .... as has been previously proven, I sold parcels at $5.28 in 2020 in the lead up to the CRL and I have said for two years that the FDA would likely consider an AA for Rexlemestrocel-L while you continuously claimed they wouldn't entertain the idea ..... I'd say my track records excels when compared to yours but whatever makes you happy


    Oh and let's not forget your purchases in P for $4 and above - that's worked out a treat for you
    Last edited by col69: 11/03/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.3¢
Change
-0.018(1.82%)
Mkt cap ! $1.090B
Open High Low Value Volume
95.5¢ 97.0¢ 94.0¢ $668.5K 703.1K

Buyers (Bids)

No. Vol. Price($)
27 61899 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 61520 44
View Market Depth
Last trade - 13.05pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.